HERG筛检市场规模、份额和成长分析（按类型、离子通道、应用和地区）- 产业预测 2025-2032

2023 年全球 HERG筛检市场规模价值 16 亿美元，预计将从 2024 年的 17.9 亿美元成长到 2032 年的 43.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.8%。

近年来，由于对药物安全的日益重视和对更有效的筛检方法的需求，全球 HERG筛检市场一直经历持续成长。製药和生物技术产业引领这个市场，并不断寻求可靠的技术来降低药物引起心律不整的风险。人们对药物心臟毒性的认识不断提高，凸显了 HERG筛检在药物开发中的重要角色。自动膜片钳系统和高通量筛检等技术进步正在刺激市场扩张。药品安全监管要求的日益严格迫使製药公司投资 HERG筛检解决方案，但高昂的前期成本对中小企业来说是一个挑战。此外，准确预测药物的心臟安全性仍然很复杂，需要持续研究来增强预测模型。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究分析

HERG筛检市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 基因 KCNH2
• 突变型 KCNH2

HERG筛检市场规模（依离子通道和复合年增长率） (2025-2032)

• 市场概况
• 电压门
• 配体门

HERG筛检市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 抗心律不整药物
• 抗发炎药物
• 抗生素
• 其他的

HERG筛检市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Cytocentrics AG（Germany）
• Charles River Laboratories（US）
• Thermo Fisher Scientific Inc.（US）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Luxembourg）
• Nanion Technologies GmbH（Germany）
• SB Drug Discovery（UK）
• B'SYS GmbH（Switzerland）
• RedShift BioAnalytics, Inc.（US）
• Icagen, Inc.（a division of Eurofins DiscoverX）（US）
• Apredica（a division of Eurofins DiscoverX）（US）
• Inotrem SA（France）
• Axxam SpA（Italy）
• Ncardia AG（Germany）

结论和建议

Global HERG Screening Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.79 billion in 2024 to USD 4.37 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

The global hERG screening market has seen consistent growth in recent years, driven by the increasing emphasis on drug safety and the demand for more efficient screening methods. The pharmaceutical and biotechnology sectors lead this market, continually seeking reliable technologies to mitigate the risk of drug-induced cardiac arrhythmias. Heightened awareness of drug cardiotoxicity has underscored the critical role of hERG screening in drug development. Advancements in technologies, such as automated patch clamp systems and high-throughput screening, are fueling market expansion. Stricter regulatory demands for drug safety compel pharmaceutical companies to invest in hERG screening solutions, although high initial costs pose challenges for smaller firms. Additionally, accurately predicting a drug's cardiac safety profile remains complex, necessitating ongoing research to enhance predictive models.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Herg Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HERG Screening Market Segmental Analysis

Global HERG Screening Market is segmented by Type, Ion Channel, Application and region. Based on Type, the market is segmented into Gene KCNH2 and Mutant KCNH2. Based on Ion Channel, the market is segmented into Voltage-Gated and Ligand-Gated. Based on Application, the market is segmented into Antiarrhythmic, Antiphyshotic, Antibiotics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HERG Screening Market

One of the primary catalysts driving the Global HERG Screening market is the increased focus on drug safety. This growing concern encourages companies to allocate resources towards the development of sophisticated screening technologies that can identify potential compounds with harmful cardiac effects early in the drug discovery process. By prioritizing the identification of safety risks, organizations aim to ensure the efficacy and reliability of their drug candidates, thereby fostering a safer pharmaceutical environment. As a result, the demand for enhanced HERG screening solutions continues to rise, reflecting the industry's commitment to prioritizing patient safety and regulatory compliance throughout the drug development lifecycle.

Restraints in the Global HERG Screening Market

One of the significant limitations in the global hERG screening market is the substantial financial burden associated with purchasing and maintaining advanced screening equipment, such as automated patch clamp systems. This high initial investment poses a particular challenge for smaller pharmaceutical companies and research institutions, hindering their ability to access and utilize the latest hERG screening technologies. As a result, these financial constraints may restrict their research capabilities and slow down the development of new drugs, ultimately impacting their competitiveness in the market. This situation creates a barrier for innovation and technological advancement within the industry.

Market Trends of the Global HERG Screening Market

The Global hERG Screening market is witnessing a notable trend towards heightened consumer awareness and the growing preference for clean label products, prompting pharmaceutical and biotechnology companies to enhance their compound screening processes. The adoption of Automated Patch Clamp Systems is gaining momentum due to their superior throughput capabilities and precise measurements, essential for identifying hERG liabilities efficiently. Additionally, the emphasis on High-Throughput Screening (HTS) technology is reshaping the landscape, enabling researchers to assess multiple compounds simultaneously, thereby accelerating the screening process. This convergence of innovation and demand for safety is driving market growth and reshaping industry practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global HERG Screening Market Size by Type & CAGR (2025-2032)

• Market Overview
• Gene KCNH2
• Mutant KCNH2

Global HERG Screening Market Size by Ion Channel & CAGR (2025-2032)

• Market Overview
• Voltage-Gated
• Ligand-Gated

Global HERG Screening Market Size by Application & CAGR (2025-2032)

• Market Overview
• Antiarrhythmic
• Antiphyshotic
• Antibiotics
• Others

Global HERG Screening Market Size & CAGR (2025-2032)

• North America (Type, Ion Channel, Application)
  • US
  • Canada
• Europe (Type, Ion Channel, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Ion Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Ion Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Ion Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cytocentrics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanion Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB Drug Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B'SYS GmbH (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RedShift BioAnalytics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icagen, Inc. (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apredica (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotrem S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axxam S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ncardia AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations